Models of determinants of COVID-19 vaccine hesitancy in non-pregnant and pregnant population: Review of current literature"
- PMID: 36345571
- PMCID: PMC9746492
- DOI: 10.1080/21645515.2022.2138047
Models of determinants of COVID-19 vaccine hesitancy in non-pregnant and pregnant population: Review of current literature"
Abstract
Vaccination has proven to be the most effective tool in controlling the COVID-19 pandemic. While pregnant individuals are considered to be a high-risk population and are more likely to experience adverse effects from COVID-19, vaccination rates among pregnant individuals are significantly lower than in the general population. The Health Belief Model (HBM), Theory of Planned Behavior (TPB), 3C model, 5C model, and 5A model have been used to assess vaccination hesitancy behaviors. In this paper, we review the use of each of these models to address vaccine hesitancy, with a focus on the pregnant population and the COVID-19 vaccine. The HBM, TPB, 3C model, and 5C model have demonstrated great versatility in their ability to evaluate, explain, and modify vaccine hesitancy and behavior. Up to date, the HBM and 3C models appear to be the most effective models to study and address vaccination hesitancy within the pregnant persons.
Keywords: 3C model; 5A model; 5C model; Vaccine hesitancy; health belief model; pregnancy; theory of planned behavior.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
References
-
- COVID Data Tracker (CDC) . Centers for Disease control and prevention. 2020. [accessed 2022 Apr 4]. https://covid.cdc.gov/covid-data-tracker/#vaccinations-pregnant-women.
-
- Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, Roggero P, Prefumo F, Silva Do Vale M, Cardona-Perez JA, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr. 2021. Aug. [accessed 2021Dec 18];175(8):1–15. doi: 10.1001/jamapediatrics.2021.1050. - DOI - PMC - PubMed
-
- Fu W, Sivajohan B, McClymont E, Albert A, Elwood C, Ogilvie G, Money D.. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants. Int J Gynaecol Obstet. 2022. Mar;156(3):406–17. doi: 10.1002/ijgo.14008. - DOI - PMC - PubMed
-
- Lipkind HS, Vazquez-Benitez G, DeSilva M, Vesco KK, Ackerman-Banks C, Zhu TG, Boyce TG, Daley MF, Fuller CC, Getahun D, et al. Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, December 15, 2020-July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022. Jan;71(1):26–30. doi: 10.15585/mmwr.mm7101e1. - DOI - PMC - PubMed
-
- Morgan JA, Biggio JR Jr, Martin JK, Mussarat N, Chawla HK, Puri P, Williams FB. Maternal outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vaccinated compared with unvaccinated pregnant patients. Obstet Gynecol. 2022. Jan;139(1):107–09. doi: 10.1097/AOG.000000000000462. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical